| Autor: |
Gerido LH; University of Michigan School of Public Health., Resnicow K; University of Michigan School of Public Health., Stoffel E; University of Michigan Rogel Cancer Center., Tomlin T; My Breast Years Ahead., Cook-Deegan R; Arizona State University., Cline M; University of California, Santa Cruz., Coffin A; Virginia Commonwealth University., Holdren J; The Light Collective., Majumder MA; Baylor College of Medicine., He Z; Florida State University. |
| Jazyk: |
angličtina |
| Zdroj: |
Research square [Res Sq] 2023 Mar 20. Date of Electronic Publication: 2023 Mar 20. |
| DOI: |
10.21203/rs.3.rs-2340760/v1 |
| Abstrakt: |
Public health genomics prioritizes effective and ethical translation of genomic science into population health precision medicine. With the rapid development of cost-effective, next-generation genome sequencing, calls are growing for greater inclusion of Black people in genomic research, policy, and practice. Genetic testing is often the first step in precision medicine. This study explores racial differences in patient concerns about genetic testing for hereditary breast cancer. Employing a community-based participatory mixed methods research design, we developed a semi-structured survey that was shared broadly. There were 81 survey respondents, of which, forty-nine (60%) self-identified as Black, twenty-six (32%) indicated they had a history of a breast cancer diagnosis, or had received BRCA genetic testing. Black participants who expressed concerns about genetic testing were fairly equally distributed between concerns that could be addressed with genetic counseling (24%) and concerns about the subsequent use of their genetic data (27%). The concerns expressed by the participants in our study underscore a need for transparent disclosures and assurances regarding the use and handling of genetic data. These findings should be viewed in context with patient-led efforts to overcome systemic inequities in cancer care, as Black cancer patients have joined forces with advocates and researchers to develop protective health data initiatives and to improve their representation in genomic datasets. Future research should prioritize the information needs and concerns of Black cancer patients. Interventions should be developed to support their hidden work as a means to reduce barriers and improve representation in precision medicine. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
